References
- Marshall WF, Keating MR, Anhalt JP, Steckelberg JM. Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc 1989; 64: 1097–104.
- Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with S. maltophilia. Clin Microbiol Rev 1998; 11: 57–80.
- Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 1996; 22: 508–12.
- Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 1994; 38: 624–7.
- Muder RR, Yu VL, Dummer JS, Vinson C, Lumish RM. Infections caused by Pseudomonas maltophilia. Arch Intern Med 1987; 147: 1672–4.
- Hong Nguyen M, Muder RR. Meningitis due to Xanthomonas maltophilia: case report and review. Clin Infect Dis 1994; 19: 325–6.
- Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ. Stenotrophomonas maltophilia meningitis. J Neurosurg 1997; 87: 106–8.
- Routsi C, Platsouka E, Dimopoulou H, Markaki B, Kaltsas P, Dimitriadou E, et al. Emergence of Stenotrophomonas maltophilia infections in Intensive Care Unit patients. Clinical and molecular analysis [Abstract]. Am J Respir Crit Care 2001; 163: A110.
- Tsiodras S, Pittet D, Carmeli Y, Eliopoulos G, Boucher H, Harbarth S. Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis 2000; 32: 651–6.